Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2026Obstetrics and Gynecology InternationalOpen Access

Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism‐Based Therapeutic Approach

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSantosh KumarRKRakesh KumarMKMohd Imran Khan

Discussion

Loading...

Member takes

Overview

Preclinical study demonstrates reduced endometriotic lesions in a mouse model with combined therapy, suggesting improved treatment options.

Key Points

  • To evaluate the efficacy of dydrogesterone and letrozole combination therapy in treating endometriosis.
  • Implemented a preclinical mouse model of endometriosis.
  • Applied dydrogesterone and letrozole in combination.
  • Monitored changes in lesion volume, cell proliferation, and inflammation.
  • Combination therapy significantly reduced endometriotic lesion volume.
  • Suppressed cell proliferation and decreased inflammation compared to control.
  • Indicated greater therapeutic effects than individual treatments and standard therapies.

Cite This Study

Kumar et al. (2026) studied this question.

synapsesocial.com/papers/6992b4139b75e639e9b08e27https://doi.org/10.1155/ogi/5464578
View Full Paper
Ask AI
Bookmark
Share